Mexico Organ Preservation Market (2025-2030)
The Mexico Organ Preservation Market was valued at $1.83 Million in 2025 and projected to reach to $2.26 Million by 2030, representing a compound annual growth rate of 4.3%. Mexico's organ preservation market is poised for steady growth as healthcare providers prioritize improving transplant outcomes and reducing organ loss.
Mexico Organ Preservation Market Trends and Insights
- Mexico's healthcare infrastructure is increasingly adopting advanced organ preservation technologies to improve transplant outcomes and reduce organ wastage.
- The market growth in Mexico is driven by rising demand for organ transplantation, improved healthcare spending, and greater awareness of preservation solutions among medical institutions. During the forecast period from 2025 to 2030, Mexico is anticipated to see steady expansion in organ preservation adoption across major transplant centers and hospitals.
- Mexico's regulatory environment and government initiatives supporting organ donation programs are creating favorable conditions for market development.
- The incremental growth reflects Mexico's gradual modernization of transplant infrastructure and increasing investment in life-saving preservation technologies..
Key Market Statistics
- CAGR (2025-2030) 4.3% CAGR
- Market Size, 2025 ~USD 1.83 Million
- Forecast, 2030 ~USD 2.26 Million
- Country Mexico
Mexico Organ Preservation Market Overview
Market Valuation :
Mexico's organ preservation market is valued at USD 1.83 million in 2025, with projected growth to USD 2.26 million by 2030, representing a steady CAGR of 4.3%.
Healthcare Infrastructure Modernization :
Mexican healthcare institutions are increasingly investing in advanced organ preservation technologies to enhance transplant success rates and minimize organ wastage across the country.
Growing Transplant Demand :
Rising prevalence of organ failure conditions and increased awareness of transplantation benefits are driving demand for sophisticated preservation solutions in Mexico's medical sector.
Regional Growth Trajectory :
Mexico's 4.3% CAGR reflects moderate but consistent market expansion, positioning the country as an emerging market for organ preservation technologies in Latin America.
Mexico Organ Preservation Market Dynamics
- Government initiatives to strengthen transplantation programs and increasing private sector investment in advanced medical technologies are key growth catalysts.
- The market will benefit from rising patient awareness and improved access to organ transplantation services across urban and semi-urban regions. Looking ahead to 2030, Mexico's market expansion will be supported by technological advancements in preservation solutions, partnerships with international medical device manufacturers, and enhanced regulatory frameworks.
- Growing healthcare expenditure and the establishment of specialized transplant centers will further accelerate market penetration, positioning Mexico as a significant contributor to Latin America's organ preservation sector..
Related Ecosystem
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- JOHNSON & JOHNSON
Key Takeaways
- Mexico's organ preservation market is valued at USD 1.83 million in 2025 with projected growth to USD 2.26 million by 2030.
- Mexico is experiencing a 4.3% CAGR, reflecting steady adoption of preservation technologies in transplant centers.
- Mexico's market growth is supported by government organ donation initiatives and improved healthcare infrastructure investment.
- Mexico's transplant sector is increasingly prioritizing organ preservation to enhance transplant success rates and reduce organ loss.
Organ Preservation Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | PERFADEX (Solution) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 6.8% from 2025 to 2030 |
| Largest Segment | ORGAN TRANSPLANT CENTERS (End User) |
| Market Size Base Year (Billions) | ~USD 0.22 (2025) |
| Revenue Forecast (Billions) | ~USD 0.3 (2030) |
| Segments Covered | Solution, Technique, Organ Type, End User |
Mexico Organ Preservation Market Report Segmentation
4 segment dimensions are covered across the global market.
By Solution
- Custodiol Htk
- Other Solutions
- Perfadex
- University Of Wisconsin Solution
By Technique
- Hypothermic Machine Perfusion
- Normothermic Machine Perfusion
- Static Cold Storage
By Organ Type
- Heart
- Kidneys
- Liver
- Lungs
- Other Organs
By End User
- Hospitals
- Organ Transplant Centers
- Specialty Clinics
Target Audience
- Medical Device Manufacturers : Manufacturers of organ preservation equipment and solutions need Mexico-specific market data to assess market potential, identify distribution channels, and develop localized product strategies.
- Healthcare Facility Operators : Hospital networks and transplant centers in Mexico require market insights to justify capital investments in preservation technologies and benchmark against regional standards.
- Investment & Private Equity Firms : Investors evaluating opportunities in Mexico's healthcare sector need detailed market sizing and growth projections to make informed funding decisions in organ preservation technologies.
- Healthcare Consultants & Advisors : Consulting firms advising Mexican healthcare institutions and international companies need country-specific market data to develop strategic recommendations and business cases.
- Government & Policy Makers : Mexican health authorities and policymakers require market intelligence to inform healthcare infrastructure planning, transplantation program development, and technology adoption initiatives.
Key Companies in the Mexico Organ Preservation Market
| Company | HQ | Ownership | Strongest segments |
|---|---|---|---|
| KINDRED HEALTHCARE INC. | United States | Private Company | Static Cold Storage–linked care (all solutions),Hypothermic machine perfusion–linked care,Normothermic perfusion–linked care, |
| XVIVO PERFUSION AB | Sweden | Public Company | Perfadex Plus and lung preservation solutions (incl. STEEN Solution),XPS EVLP systems, lung kits, organ chambers, cannula sets,Kidney Assist (Transport and multi-mode) platforms and related solutions, |
| TRANSMEDICS, INC. | United States | Public Company | OCS Heart,OCS Lung,OCS Liver, |
| BIOLIFE SOLUTIONS, INC. | United States | Public Company | HypoThermosol FRS (hypothermic preservation media),CryoStor Freeze Media,evo Shipping Containers (cold-chain transport), |
| SHANGHAI GENEXT MEDICAL TECHNOLOGY CO., LTD. | China | Private Company | UW and Custodial HTK-equivalent preservation solutions,Perfadex-type and lung/heart-focused perfusion solutions,Preservation and transport devices (static cold storage, hypothermic, normothermic platforms), |
KINDRED HEALTHCARE INC.
Kindred Healthcare Inc. is a United States-based private company founded in 1985 that operates as a major healthcare services provider with 64,200 employees.
XVIVO PERFUSION AB
XVIVO Perfusion AB is a Swedish public company founded in 1998 with 199 employees operating in the medical device and perfusion technology sector.
TRANSMEDICS, INC.
TransMedics, Inc. is a United States-based public company founded in 1998 with 898 employees specializing in organ preservation and transplant technology.
BIOLIFE SOLUTIONS, INC.
BioLife Solutions, Inc. is a United States-based public company founded in 1987 with 155 employees providing biopreservation solutions for cell and tissue therapies.
SHANGHAI GENEXT MEDICAL TECHNOLOGY CO., LTD.
Shanghai Genext Medical Technology Co., Ltd. is a Chinese private company founded in 2004 with 62 employees specializing in medical technology development.
Reasons to Buy this Report
- Market-Specific Sizing & Forecasts : Access precise valuation data for Mexico's organ preservation market (USD 1.83M in 2025, USD 2.26M in 2030) with detailed CAGR analysis to support investment and expansion decisions.
- Competitive Landscape Intelligence : Understand Mexico-specific market dynamics, key players, and competitive positioning to identify partnership opportunities and market entry strategies in this emerging healthcare segment.
- Growth Driver Analysis : Gain insights into Mexico's unique growth catalysts including healthcare infrastructure modernization, rising transplant demand, and regulatory developments shaping market expansion.
- Strategic Market Positioning : Leverage Mexico-focused data to benchmark performance, identify market gaps, and develop targeted strategies for medical device manufacturers and healthcare service providers.
- Regional Expansion Planning : Use Mexico market intelligence as a foundation for broader Latin American expansion strategies, with clear understanding of local healthcare adoption patterns and investment priorities.
Frequently asked questions
What is the current size of Mexico's organ preservation market?
Mexico's organ preservation market is valued at USD 1.83 million in 2025 and is projected to reach USD 2.26 million by 2030.
What is the growth rate of Mexico's organ preservation market?
Mexico's organ preservation market is growing at a CAGR of 4.3% from 2025 to 2030.
What factors are driving growth in Mexico's organ preservation market?
Mexico's market growth is driven by rising organ transplant demand, increased healthcare spending, government donation initiatives, and adoption of advanced preservation technologies.
Which institutions are leading organ preservation adoption in Mexico?
Major transplant centers and hospitals across Mexico are increasingly adopting organ preservation solutions to improve transplant outcomes and reduce organ wastage.
How does Mexico's organ preservation market compare to other Latin American countries?
Mexico represents a significant portion of the Latin American organ preservation market, with steady growth reflecting its healthcare infrastructure modernization and transplant program expansion.
RESEARCH METHODOLOGY
The study involved four major activities to estimate the current size of the organ preservation market—exhaustive secondary research collected information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the market size of the segments and subsegments.
Secondary Research
In the secondary research process, various sources were utilized to identify and gather information to study the organ preservation market. These sources included company annual reports, press releases, investor presentations, white papers, certified publications, and articles by recognized authors. We also consulted reputable websites, regulatory bodies, and databases such as D&B Hoovers, Bloomberg Business, and Factiva.
This research aimed to gather crucial information about the leading companies in the industry, market classification, and segmentation based on industry trends down to the most detailed levels, including geographic markets. Additionally, we focused on key developments related to the market. Through this secondary research, a database of key industry leaders was created.
Primary Research
Extensive primary research was conducted after gathering information about the organ preservation market through secondary research. Several primary interviews were held with market experts from both the demand and supply sides across major regions, including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. Data was collected through questionnaires, emails, and telephone interviews. The primary sources from the supply side included various industry experts, such as Chief Executive Officers (CEOs), Vice Presidents (VPs), Directors of business development, marketing, product development/innovation teams, and other key executives from manufacturers and distributors operating in the organ preservation market, as well as key opinion leaders.
The following is a breakdown of the primary respondents:
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The research methodology used to estimate the size of the organ preservation market includes the following details.
The market sizing was undertaken from the global side.
Country-level Analysis: The size of the organ preservation market was obtained from the annual presentations of leading players and secondary data available in the public domain. Shares of products in the overall organ preservation market were obtained from secondary data and validated by primary participants to arrive at the total organ preservation market. Primary participants further validated the numbers.
Geographic Market Assessment (By Region & Country): The geographic assessment was done using the following approaches:
Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends
Approach 2: Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)
Industry experts contacted during primary research validated the assumptions and approaches at each point. Considering the limitations of data available from secondary research, revenue estimates for individual companies (for the overall organ preservation market and geographic market assessment) were ascertained based on a detailed analysis of their respective product offerings, geographic reach/strength (direct or through distributors or suppliers), and the shares of the leading players in a particular region or country.
Global Organ Preservation Market Size: Bottom-up Approach & Top-down Approach
Data Triangulation
The market was split into several segments and subsegments after arriving at the overall market size—using the market size estimation processes. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and determine each market segment's and subsegment's exact statistics. The data was triangulated by studying various factors and trends from both the demand and supply sides in the organ preservation market.
Market Definition
Organ preservation solutions are used to protect and preserve the viability of organs during organ transplantation. Utilizing distinct methodologies, organ preservation starts with the surgical removal of the donor organ and concludes with its placement in the recipient. Various solutions (such as the University of Wisconsin solution and Custodiol HTK) and techniques (such as static cold storage and hypothermic machine perfusion) are used to preserve organs.
Stakeholders
- Association of Organ Procurement Organizations (AOPO)
- American Transplant Congress (ATC)
- United Network for Organ Sharing (UNOS)
- Network & Alliance of Transplant Coordinators (NATCO)
- Consortium for Organ Preservation in Europe (COPE)
- European Society for Organ Transplantation (ESOT)
- Asian Society of Transplantation (AST)
- National Health Service (UK NHS)
- International Registry on Organ Donation and Transplantation (IRODaT)
- Global Observatory on Donation and Transplants (GODT)
- National Institutes of Health (NIH)
- World Health Organization (WHO)
- Organisation for Economic Co-operation and Development (OECD)
- Centers for Disease Control and Prevention (CDC)
- Annual Reports/SEC Filings, Investor Presentations, and Press Releases of Key Players
- White Papers, Journals/Magazines, and News Articles
Report Objectives
- To define, describe, and forecast the organ preservation market based on solution, technique, organ type, end user, and region
- To provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and challenges)
- To strategically analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall organ preservation market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for market players
- To estimate the market size and growth potential of the market segments with respect to six regions: North America, Europe, Asia Pacific, Latin America, the Middle East & Africa, and GCC Countries
- To profile the key players operating in the organ preservation market and comprehensively analyze their revenue shares and core competencies2
- To track and analyze competitive developments such as product launches & approvals, partnerships, agreements, collaborations, expansions, joint ventures, and acquisitions in the organ preservation market
- To benchmark players in the market using the proprietary Competitive Leadership Mapping framework, which analyzes market players on various parameters within the broad categories of business strategy and product offering
Get the Full Organ Preservation Market Report
Full forecast, segment splits, and company analysis for all Organ Preservation Market.
- US Organ Preservation Market
- Canada Organ Preservation Market
- Germany Organ Preservation Market
- France Organ Preservation Market
- UK Organ Preservation Market
- Spain Organ Preservation Market
- Italy Organ Preservation Market
- China Organ Preservation Market
- Japan Organ Preservation Market
- India Organ Preservation Market
- Australia Organ Preservation Market
- South Korea Organ Preservation Market
- Brazil Organ Preservation Market
- GCC Countries Organ Preservation Market
- Roe Organ Preservation Market
- Rest Of Asia Pacific Organ Preservation Market
- Rest Of Europe Organ Preservation Market
- Rest Of Latin America Organ Preservation Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report